Call for tenders: Next Generation Sequencing for Oncology

Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost reduction and technology acceleration. 8 health procurers from 5 countries (BE, FR, DE, ES, IT) invite potentially interested bidders to submit an offer for their oncNGS pre-commercial procurement.

Aim of the procurement is to develop an affordable integrated solution for predictive, prognostic and diagnostic analysis in liquid biopsies of solid tumours based on NGS technology. Deadline for submission of offers: extended to 17 October 2022.

Tags:

ads
  • Show Comments

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

You May Also Like

Startup Europe Summit 2018

The European Startup Event comes to Sofia. This time it will be about technology ...

€17.5 million in financing for innovative companies under the European Innovation Council

Innovative companies can apply for up to €17.5 million in combined grant and equity ...

X
/